Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Dec 27, 2021; 13(12): 1696-1707
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1696
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1696
Before PSM (n: 77) | After PSM (n: 52) | |||||||||
RFA (n: 40) | Surgery (n: 37) | P value | RFA (n: 26) | Surgery (n: 26) | P value | |||||
Male, n (%) | 28 (70) | 27 (73) | 0.80 | 17 (65) | 16 (62) | 1.0 | ||||
Age (yr) median (range) | 74.5 (70-87) | 74.98 (70-83) | 0.80 | 75 (70-81) | 74.26 (70-81) | 0.43 | ||||
BMI (kg/cm²) median (range) | 26.7 (19-51) | 26.7 (22-36) | 0.90 | 26.7 (19-51) | 26.7 (22-36) | 0.48 | ||||
Comorbidity ≥ 2, n (%) | 23 (57) | 14 (38) | 0.10 | 12 (46) | 10 (40) | 0.78 | ||||
Cause of cirrhosis, n (%) | 0.30 | 0.71 | ||||||||
Hepatitis C virus, n (%) | 21 (53) | 19 (50) | 16 (61) | 16 (61) | ||||||
Hepatitis B virus, n (%) | 5 (12) | 10 (27) | 4 (15) | 6 (23) | ||||||
Alcohol, n (%) | 6 (15) | 4 (12) | 3 (12) | 1 (4) | ||||||
Others, n (%) | 8 (20) | 4 (11) | 3 (12) | 3 (12) | ||||||
F4 cirrhosis, n (%) | 33 (82) | 19 (51) | 0.01 | 22 (85) | 12 (46) | 0.01 | ||||
ASA score, n (%) | 0.05 | 0.35 | ||||||||
I/II, n (%) | 11 (28) | 19 (51) | 10 (40) | 11 (42) | ||||||
III/IV, n (%) | 29 (72) | 18 (49) | 16 (61) | 15 (58) | ||||||
Preoperative blood tests median (range) | ||||||||||
Bilirubin (µmol/L) median (range) | 1 (1-1.1) | 1 (1-2) | 0.55 | 1 (1-1.1) | 1 (1-1) | 0.90 | ||||
Platelet count × 109/L median (range) | 118 (52-380) | 173 (55-387) | 0.01 | 137 (69-380) | 183 (55-340) | 0.06 | ||||
INR median (range) | 1 (1-2) | 1 (1-2) | 0.40 | 1 (1-1.2) | 1 (1-2) | 0.06 | ||||
AFP (mg/mL) median (range) | 5 (1-1988) | 12.5 (2-3900) | 0.14 | 6.5 (1-1988) | 7 (2-3900) | 0.64 | ||||
Child-Pugh, n (%) | 0.20 | 0.06 | ||||||||
A | 37 (93) | 30 (81) | 26 (100) | 21 (81) | ||||||
B | 3 (7) | 7 (19) | 0 (0) | 5 (19) | ||||||
MELD median (range) | 8 (6-15) | 6 (6-16) | 0.01 | 8 (6-15) | 7 (6-16) | 0.23 | ||||
Tumors size (mm) median (range) | 23 (10-30) | 29 (12-30) | 0.02 | 20.5 (10-30) | 23 (15-30) | 0.08 | ||||
Tumor locations, n (%) | 0.10 | 0.45 | ||||||||
4a | 3 (7) | 3 (8) | 2 (8) | 2 (8) | ||||||
7 | 8 (20) | 17 (46) | 4 (15) | 9 (34) | ||||||
8 | 23 (58) | 14 (38) | 17 (65) | 13 (50) | ||||||
7-8 | 6 (15) | 3 (8) | 3 (12) | 2 (8) | ||||||
Histological proven, n (%) | 7 (17) | 8 (22) | 0.80 | 6 (23) | 8 (31) | 0.75 |
- Citation: Delvecchio A, Inchingolo R, Laforgia R, Ratti F, Gelli M, Anelli MF, Laurent A, Vitali G, Magistri P, Assirati G, Felli E, Wakabayashi T, Pessaux P, Piardi T, di Benedetto F, de'Angelis N, Briceño J, Rampoldi A, Adam R, Cherqui D, Aldrighetti LA, Memeo R. Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients. World J Gastrointest Surg 2021; 13(12): 1696-1707
- URL: https://www.wjgnet.com/1948-9366/full/v13/i12/1696.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i12.1696